missing translation for 'onlineSavingsMsg'
Learn More
Learn More
BTX™ BTXPress™ Electroporation Buffer Kit
BTXPress™ Electroporation Buffer Kit offers a single buffer solution developed to quickly and efficiently deliver genes into mammalian cells that were previously considered hard to transfect by chemical and other non-viral methods.
Brand: BTX™ 450807
This item is not returnable.
View return policy
Description
BTXPress™ Electroporation Solution is the first electroporation reagent that meets all of your high performance transfection needs without sacrificing control over your experiment or your budget. It offers increased numbers of transfections per kit compared to other commercial alternatives, providing higher value to you. As a universal solution, the BTXPress™ Electroporation Solution can be used in other electroporators, including the Amaxa™, to deliver similar results without the typical high cost associated with these buffer kits. The BTXPress™ Electroporation Solution is offered as a kit including the BTX™ cuvettes Plus with transfer pipettes or as a buffer alone.
- Efficient electroporation transfection
- High efficiency transfection of difficult cell lines
- High cell viability
- Low toxicity resulting in improved cell viability
- Single buffer for all cell types
- One buffer used in place of standard electroporation buffers for all mammalian cell types
Specifications
| Universal Electroporatuion Buffer | |
| BTXpress Solution Kit 40 Reactions in 4 mm gap Cuvettes | |
| Cells | |
| Electroporation | |
| Transfection via Electroporation | |
| 4 mm Cuvettes | |
| BTX Electroporation | |
| 4 Bags (10 Cuvettes/Bag), 10 mL Buffer | |
| 10 mL |
| 2°C to 8°C | |
| Mammalian | |
| None (Promoterless) | |
| BTX™ and other electroporators | |
| 10 mL Solution, 40 x 4 mm gap Cuvettes and Transfer Pipette | |
| 40 | |
| Electroporation Buffer | |
| Sterile |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction